Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00575536 · ClinicalTrials.gov registry record

Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures

A clinical trial of Spasticity, sponsored by Vanderbilt University.

Completed
Registry status
19
Enrollment target
1
Study location

NCT00575536: Completed study of Spasticity, sponsored by Vanderbilt University.

NCT00575536 is a study of Spasticity that has completed, run by Vanderbilt University. The registered enrollment target is 19 participants, below the 89-participant average among 8 other Spasticity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00575536, a study of Spasticity, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
19 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the safe and effective levels of optical stimulation in peripheral nerves of humans otherwise undergoing nerve lesioning in surgery.

Conditions Studied

Interventions

  • PROCEDURE Rhizotomy for children with spasticity

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2006-01
Est. Completion 2017-11
Vanderbilt University

430 total trials

What the finished NCT00575536 record still lists

NCT00575536 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 89-participant average among 8 other Spasticity trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Spasticity appearing as the primary indexed condition, and to 1 intervention - of which Rhizotomy for children with spasticity is the first listed.

NCT00575536 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT00575536 about?

NCT00575536 is a clinical study titled "Optical Stimulation in Peripheral Nerves for Select Rhizotomy Procedures". The purpose of this study is to determine the safe and effective levels of optical stimulation in peripheral nerves of humans otherwise undergoing nerve lesioning in surgery.

What is the current status of trial NCT00575536?

This trial is currently completed. The enrollment target is 19 participants. The study started on 2006-01. Estimated completion is 2017-11.

What conditions does trial NCT00575536 study?

This clinical trial studies the following conditions: Spasticity.

What interventions are being tested in trial NCT00575536?

The interventions under investigation include: Rhizotomy for children with spasticity (PROCEDURE).

Who is sponsoring clinical trial NCT00575536?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00575536 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spasticity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00575536's enrollment target sits among peer trials

19 6th of 8 higher than 3 of 8 other Spasticity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spasticity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00575536, the US trial registry maintained by the National Library of Medicine. NCT00575536 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.